WallStreetZenWallStreetZen

NASDAQ: CTCX
Carmell Corp Earnings & Revenue

CTCX past revenue growth

How has CTCX's revenue growth performed historically?
Company
82.88%
Industry
110.58%
Market
14.02%
CTCX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTCX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CTCX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CTCX earnings and revenue history

Current Revenue
$25.6M
Current Earnings
-$19.3M
Current Profit Margin
-75.1%

CTCX Return on Equity

Insufficient data to display

Be the first to know when CTCX announces earnings.

CTCX Return on Assets

Current Company
-72.1%
Current Industry
2.2%
CTCX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTCX Return on Capital Employed

Current Company
-36.72%
Current Industry
17.7%

CTCX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTCX$25.65M-$15.63M-$19.27M+82.88%N/A
APLM$0.00-$387.20M-$388.09MN/AN/A
ATHA$0.00-$119.35M-$120.52MN/AN/A
NKGN$77.00k-$78.39M-$83.67M-84.69%N/A
CGEN$7.50M-$32.95M-$33.46M-5.59%N/A

Carmell Earnings & Revenue FAQ

What were CTCX's earnings last quarter?

Carmell (NASDAQ: CTCX) reported Q3 2023 earnings per share (EPS) of -$0.62, up 90.8% year over year. Total Carmell earnings for the quarter were -$11.51 million. In the same quarter last year, Carmell's earnings per share (EPS) was -$6.74.

If you're new to stock investing, here's how to buy Carmell stock.

What was CTCX's earnings growth in the past year?

As of Q4 2023, Carmell's earnings has grown year over year. Carmell's earnings in the past year totalled -$19.27 million.

What was CTCX's revenue last quarter?

Carmell (NASDAQ: CTCX) reported Q3 2023 revenue of $3.73 million up Infinity% year over year. In the same quarter last year, Carmell's revenue was $0.00.

What was CTCX's revenue growth in the past year?

As of Q4 2023, Carmell's revenue has grown 82.88% year over year. This is 27.7 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Carmell's revenue in the past year totalled $25.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.